Genetic Analysis

How Will PrimeStack Revolutionize Large-Scale Gene Editing?
Research & Development How Will PrimeStack Revolutionize Large-Scale Gene Editing?

Using junction-specific PCR analyses, researchers confirmed that PrimeStack can achieve success rates that are significantly higher than traditional targeted insertion methods. This breakthrough addresses a challenge that has frustrated plant scientists for decades: the extreme difficulty of

How Is GraTools Simplifying Pangenome Analysis?
Tech & Innovation How Is GraTools Simplifying Pangenome Analysis?

Modern genomic medicine requires tools that can capture the genetic diversity of global populations rather than relying on a single European-centric reference. This demand has catalyzed the development of GraTools, an advanced software solution engineered to handle the complexities inherent in

AI Agents Automate Omics Data Synthesis and Reanalysis
Tech & Innovation AI Agents Automate Omics Data Synthesis and Reanalysis

While multi-terabyte raw sequencing files are theoretically accessible to the public, the specialized knowledge required to align and analyze them creates a persistent data reuse gap. This bottleneck has long prevented the scientific community from fully leveraging the trillions of dollars invested

Is CFH or FHL-1 the Key to Better Cancer Prognostics?
Research & Development Is CFH or FHL-1 the Key to Better Cancer Prognostics?

Recent research suggests that the prognostic value of the CFH gene may be driven primarily by the FHL-1 isoform rather than the circulating full-length protein. In the rapidly shifting landscape of 2026 oncology, identifying reliable prognostic biomarkers has become the cornerstone of improving

Can β-Catenin Inhibitors Treat Endometrial Cancer?
Research & Development Can β-Catenin Inhibitors Treat Endometrial Cancer?

Transcriptomic profiling reveals that suppressing β-catenin in specific mutant cells leads to an overwhelming accumulation of ubiquitinated proteins and cellular stress. This biological response marks a turning point in the treatment of advanced endometrial cancer, which remains a leading cause of

FDA Rebuilds Advisory Committees to Reshape Clinical Trials
Research & Development FDA Rebuilds Advisory Committees to Reshape Clinical Trials

The resignation of FDA Commissioner Marty Makary on May 12, 2026, effectively unblocked the administrative queue for scheduling critical drug and device advisory meetings. This shift signals a broader effort to revitalize a system that has long been the backbone of regulatory transparency. The

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later